Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Gislaine Oliveira-Duarte"'
Autor:
Arthur Gomes Oliveira Braga, Katia Borgia Barbosa Pagnano, Marina Dal'Bó Pelegrini Campioni, Ana Beatriz Pascoal Lopes, Gislaine Oliveira Duarte, Konradin Metze, Irene Lorand-Metze
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 3, Pp 268-272 (2024)
Introduction: Treatment-free remission (TFR) is successful in half of the patients with chronic myeloid leukemia who discontinue Imatinib (IM) after sustained molecular response. Methods: In a prospective trial, we used pioglitazone for 3 months befo
Externí odkaz:
https://doaj.org/article/844ca4a2161b431180b6697474d2849e
Autor:
Muriel Silva Moura, Thais Celi Lopes Benevides, Marcia Torresan Delamain, Gislaine Oliveira Duarte, Priscila Oliveira Percout, Maria Almeida Dias, Roberto Zulli, Carmino Antonio de Souza, Irene Lorand-Metze, Katia Borgia Barbosa Pagnano
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 4, Pp 329-334 (2019)
Introduction: The incidence of grade 3–4 anemia was reported to be 3% with imatinib therapy for newly diagnosed chronic myeloid leukemia (CML) in the chronic phase (CP). However, there are few data regarding the causes and the development of anemia
Externí odkaz:
https://doaj.org/article/214c7951e2014ffda148b92eb53b2649
Autor:
Beatriz Felicio Ribeiro, Eliana C.M. Miranda, Dulcinéia Martins de Albuquerque, Márcia T. Delamain, Gislaine Oliveira-Duarte, Maria Helena Almeida, Bruna Vergílio, Rosana Antunes da Silveira, Vagner Oliveira-Duarte, Irene Lorand-Metze, Carmino A. De Souza, Katia B.B. Pagnano
Publikováno v:
Clinics, Vol 70, Iss 8, Pp 550-555 (2015)
OBJECTIVE:To evaluate hematological, cytogenetic and molecular responses as well as the overall, progression-free and event-free survivals of chronic myeloid leukemia patients treated with a third tyrosine kinase inhibitor after failing to respond to
Externí odkaz:
https://doaj.org/article/a4a165ab80c94083b9607aae3a73c740
Autor:
GC Pavan, Fvp Souza, Marcia Torresan Delamain, Carmino Antonio De Souza, Gbd Amarante, Samuel de Souza Medina, K.B.B. Pagnano, Bruna de A Murbach, IM Toni, Gislaine Oliveira Duarte, Erich Vinicius De Paula, Jessica Cn Vianna, Bruna Vergilio
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S131-S132 (2021)
Objetivos Avaliar a efetividade e eficiencia de um protocolo de descontinuacao de inibidores de tirosina quinase (ITK) em tratamento no Sistema Unico de Saude (SUS) que incluiu uma fase de descalonamento de dose antes da interrupcao do tratamento. Ma
Autor:
IM Toni, Ibr Filgueiras, Gislaine Oliveira Duarte, Leandro Freitas, Eps Silva, K.B.B. Pagnano, GC Furlin, Irene Lorand-Metze
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S144-(2021)
Introdução: A Calreticulina (CALR) é uma proteína sinalizadora celular que participa da modulação entre a fase proliferativa e maturativa dos eritroblastos. Sua função está intrinsecamente relacionada à eritropoetina (EPO) e a ativação da
Autor:
Gislaine Oliveira Duarte, Konradin Metze, Celso Dario Ramos, Fernando V Pericole, Irene Lorand-Metze, Camila Mosci, Maria Emilia Seren Takahashi
Publikováno v:
Nuclear medicine communicationsReference. 42(12)
The parameter intensity of bone involvement (IBI) was recently proposed to quantitatively assess patients with multiple myeloma using 18F-fluorodeoxyglucose-PET combined with computed tomography (18F-FDG PET/CT) images. Here, we aimed to calculate IB
Autor:
Thais Celi Lopes Benevides, Gislaine Oliveira Duarte, Irene Lorand-Metze, Roberto Zulli, Marcia Torresan Delamain, Carmino Antonio De Souza, Priscila de Oliveira Percout, Maria Almeida Dias, Katia B Pagnano, Muriel Silva Moura
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 4, Pp 329-334 (2019)
Hematology, Transfusion and Cell Therapy, Volume: 41, Issue: 4, Pages: 329-334, Published: 25 NOV 2019
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 41, Issue: 4, Pages: 329-334, Published: 25 NOV 2019
Hematology, Transfusion and Cell Therapy
Introduction: The incidence of grade 3–4 anemia was reported to be 3% with imatinib therapy for newly diagnosed chronic myeloid leukemia (CML) in the chronic phase (CP). However, there are few data regarding the causes and the development of anemia
Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
Autor:
Ariella Cássia de Moura, Katia B Pagnano, Gislaine Oliveira Duarte, Marcia Torresan Delamain, Irene Lorand-Metze, Carmino Antonio De Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 2, Pp 125-128 (2019)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 41, Issue: 2, Pages: 125-128, Published: 10 JUN 2019
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 41, Issue: 2, Pages: 125-128, Published: 10 JUN 2019
We analyzed the management and outcomes of pregnancies of patients with chronic myeloid leukemia at a single center over fifteen years. Among the 203 CML female patients, there were ten pregnancies in seven women, all of them not planned. In three ca
Autor:
Brian G.M. Durie, Juan Ramon Navarro, Gislaine Oliveira Duarte, Chor Sang Chim, Guillermo J. Ruiz-Argüelles, Wenming Chen, Rosane Bittencourt, Kihyun Kim, Jae Hoon Lee, David Gómez-Almaguer, Edvan de Queiroz Crusoe, Angelo Maiolino, Dorotea Fantl, Guillermo Conte, Shang Y.I. Huang, Gracia Martinez, Kazuyuki Shimizu, Wee Joo Chng, Weerasak Nawarawong, Vania Hungria
Publikováno v:
Annals of Hematology. 98:941-949
In previous observational studies, we have separately characterized patients with multiple myeloma (MM) both from Latin America (LA) and from Asia. Here, we analyze these two datasets jointly, in order to assess the overall survival (OS) in these two
Autor:
Graziele Cristina Pavan Furlin, Eliana C M Miranda, Katia B Pagnano, Erich Vinicius De Paula, Matheus Sebastian Da Silva, Marcia Torresan Delamain, Ana Beatriz Pascoal Lopes, Bruna R V Rodrigues, Jessica Cn Vianna, Carmino Antonio De Souza, Valquíria Mariane Oliveira Póvoa, Gislaine Oliveira Duarte
Publikováno v:
American Journal of Hematology. 95